Decision 18-D-17 of 20 September 2018 regarding practices implemented in the management of infectious medical waste generated by healthcare institutions in Corsica
Presentation of the decision
Information about the decision
20 September 2018: Management of infectious medical waste generated by healthcare activities
Decision 18-D-08 of 14 June 2018 regarding the compliance with commitments taken in the framework of the authorization of the takeover of Dolisos by Boiron in the homeopathy sector
Decision 18-D-01 regarding practices implemented by the National Order of Nurses (Ordre national des infirmiers) in the sector of supply of services to nurses
Presentation of the decision
Information about the decision
Decision of
regarding practices implemented in the sector of transdermal patches of fentanyl
Presentation of the decision
Information about the decision
The Autorité de la concurrence imposes a fine of 25 million euros on Janssen-Cilag laboratory and its parent company Johnson & Johnson for having first prevented then restricted the development of generic versions of Durogesic, its originator medicinal product.
